Sawai Group Holdings Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SWGHF research report →
Price Chart
About the company
Sawai Group Holdings Co. , Ltd. , along with its subsidiaries, specializes in the research, development, manufacture, and commercialization of generic pharmaceuticals, primarily serving markets in Japan and the United States.
- CEO
- Mitsuo Sawai
- IPO
- 2021
- Employees
- 3,630
- HQ
- Osaka, OS, JP
Get TickerSpark's AI analysis on SWGHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.33B
- P/E
- 21.80
- Fwd P/E
- 0.08
- PEG
- 0.51
- P/S
- 0.88
- P/B
- 0.85
- EV/EBITDA
- 13.14
- Div Yield
- 3.35%
- Gross Margin
- 28.70%
- Op Margin
- 9.03%
- Net Margin
- 3.96%
- ROE
- 4.51%
- ROIC
- 3.98%
Latest fiscal year · YoY change
- Revenue
- $202.95B+7.4%
- Gross Profit
- $59.16B+5.0%
- Op Income
- $20.48B
- Net Income
- $10.50B-54.2%
- EPS
- $91.07-50.8%
- OCF Growth
- -73.1%
- FCF Growth
- -1886.5%
- 52W High
- $11.52
- 52W Low
- $11.52
- 50D MA
- $11.52
- 200D MA
- $11.52
- Beta
- 0.03
- RSI (14)
- 48
- Avg Volume
- 5
No earnings-call transcripts are available for SWGHF yet.
- Free Float
- 90.7%
- Shares Outstanding
- 115.49M
- Float Shares
- 104.79M
Our SWGHF coverage
Recent articles, reports, and earnings notes.
No research on SWGHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SWGHF report →